A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy

Status:
Completed

Trial end date:
2019-01-25

Target enrollment:

Participant gender:

The purpose of this trial is to assess the efficacy and safety of Xyrem in pediatrics subjects with narcolepsy that includes cataplexy.

Phase 3

Jazz Pharmaceuticals

Sodium Oxybate